Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 16 kwi 2014 · Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals.

  2. Company profile page for EPIRUS Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact information.

  3. 19 mar 2012 · Here in 2012, Zalicus (ZLCS) is re-emerging on the biotech scene as a great investment opportunity offering substantial gains. I have put together this highly investigative report to explain why...

  4. 8 maj 2013 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (“Lincoln Park”) an institutional investor.

  5. Find the latest (ZLCS) stock quote, history, news and other vital information to help you with your stock trading and investing.

  6. 28 mar 2011 · Early Friday morning, JMP Securities issued a "Market Outperform" rating for Zalicus Inc. (ZLCS) and a "target" of $5 per share. Shares jumped 5%-6% on the JMP Securities news following the...

  7. 8 paź 2024 · Find the latest ZLCS, ZLCS stock market data. Get a full understanding of how ZLCS is performing with stock quotes and prices, as well as real-time news and analysis.

  1. Ludzie szukają również